✕
☰

Event: Access to Safe Medicines Europe Forum

by

The Access to Safe Medicines Europe Forum (ASM Europe) 2016 will take place on 19-20 January 2016 at the Sheraton Skyline, Heathrow, London

The Falsified Medicines Directive (FMD) came into force in January 2013 and requires that a unique identifier code and tamper evident safety feature must be provided for nearly all prescription medicines available in the EU.

In October 2015 the European Commission’s (EC) health directorate published its new regulation specifying the characteristics of the unique identifier code.

ASM Europe will address the key challenges facing pharma manufacturers and distributors in adapting to the requirements of the FMD and EC.

The forum will bring together 150 speakers from pharmaceutical manufacturers and distributors, packaging companies, public health and regulatory bodies and specialist technology and service providers.

Event speakers will explain how to meet the requirements of the FMD and EC, examine its shortcomings and what pharma companies should consider over and above its requirements.

There will also be speakers from countries within and outside the EU explaining what they are already doing in medicines supply chain control and monitoring.

To register for the event click here.

Back to topbutton